Neuromodulation Technology at the Neural Interface Journal Citation Rate 2026

ISSN 1094-7159 eISSN 1525-1403 Elsevier BV US

Q3 Quartile

About Neuromodulation Technology at the Neural Interface
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Neuromodulation Technology at the Neural Interface (NTNI) is a peer-reviewed academic journal covering Musculoskeletal pain and rehabilitation and Neurological disorders and treatments, published by Elsevier BV in US, catalogued under ISSN 1094-7159 (e-ISSN 1525-1403). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 0.39 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$3710 USD). OpenAlex records 6,642 works and 65,640 citations, with an h-index of 96.

Neuromodulation Technology at the Neural Interface Citation Rate 2026 — In Context

Neuromodulation Technology at the Neural Interface has a 2025 2-Year Citation Rate (OpenAlex) of 0.39, placing it in the Q3 quartile within the Musculoskeletal pain and rehabilitation research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Neuromodulation Technology at the Neural Interface operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Neuromodulation Technology at the Neural Interface should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Neuromodulation Technology at the Neural Interface against similar journals in the field, use our journal comparison tool.

Submission Tips for Neuromodulation Technology at the Neural …
  • Budget $3710 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Musculoskeletal pain and rehabilitation, Neurological disorders and treatments, Pain Management and Treatment. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Neuromodulation Technology at … Compares
Citation Rate vs Field Avg
-82%
Field avg: 2.13
APC vs Field Avg
+12%
Field avg: $3312

Compared against 33 journals in the same research areas.

ISSN (Print) 1094-7159
ISSN (Online) 1525-1403
Publisher Elsevier BV
Country United States
APC / Cost $3710 USD
In-depth profile & metrics

Neuromodulation Technology at the Neural Interface is published by Elsevier BV and based in United States. It runs on a subscription or hybrid model with an article-processing charge of USD 3710.

In our subject taxonomy, Neuromodulation Technology at the Neural Interface is classified under Musculoskeletal pain and rehabilitation, Neurological disorders and treatments, Pain Management and Treatment and Pain Mechanisms and Treatments.

Neuromodulation Technology at the Neural Interface is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 0.390.

Research Areas
Links
Frequently Asked Questions about Neuromodulation Technology at the Neural …

Neuromodulation Technology at the Neural Interface does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 0.390 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Neuromodulation Technology at the Neural Interface is not an open access journal.

The Article Processing Charge (APC) for Neuromodulation Technology at the Neural Interface is $3710 USD.

Neuromodulation Technology at the Neural Interface is published by Elsevier BV.

Neuromodulation Technology at the Neural Interface shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Neuromodulation Technology at the Neural Interface is 1094-7159. Its electronic ISSN (eISSN) is 1525-1403.

Neuromodulation Technology at the Neural Interface sits in the Q3 quartile based on its latest impact factor of 0.39, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
0.390
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 0.390 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S121762105

Get weekly updates for Musculoskeletal pain and rehabilitation journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google